Sanofi

Merck, Sanofi in Deals for Cancer Drug Firms
M&A

Merck, Sanofi in Deals for Cancer Drug Firms

The pharma giants each announced they would buy smaller drugmakers to expand cancer-treatment franchises.
By Lauren Muskett | December 9, 2019
Read More
Sanofi Buys Hemophilia Drug Maker for $11B
Strategy

Sanofi Buys Hemophilia Drug Maker for $11B

The acquisition of Bioverativ boosts Sanofi's presence in the fast-growing, $10 billion market for hemophilia treatments.
By Matthew Heller | January 22, 2018
Read More